This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Opinion/comment
Opinion/comment
SIMPONI® (golimumab) gains positive opinion from CHMP for the treatment of nr-axial SpA
Bristol-Myers Squibb receives positive CHMP opinion of new ORENCIA® (abatacept)
Daiichi Sankyo’s Once-Daily Lixiana® (edoxaban) receives positive CHMP opinion
Tresiba® receives positive opinion from CHMP for treatment of children with diabetes
To the editor:
Nintedanib receives positive CHMP opinion in EU for the treatment of Idiopathic Pulmonary Fibrosis
Victoza® receives positive CHMP opinion
Celgene receives positive CHMP opinion for OTEZLA® (apremilast)
Lynparza™ (olaparib) receives positive CHMP opinion in the EU
CHMP positive opinion for Xultophy?
Triumeq® regimen receives positive opinion
Eliquis receives ‘positive opinion’ from EMA
« Previous
1
…
7
8
9
10
11
…
21
Next »
Most read
1
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: